Super-Hypofractionated Partial Breast Irradiation
- Conditions
- Breast CancerRadiotherapy Side Effect
- Interventions
- Radiation: Partial Breast Irradiation
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2024-09-26
- Target Recruit Count
- 50
- Registration Number
- NCT06615466
- Locations
- 🇨🇳
Cancer Hospital ,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
- Conditions
- Whole Brain Radiotherapy
- Interventions
- Drug: Antirotinib hydrochloride
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2024-10-16
- Target Recruit Count
- 40
- Registration Number
- NCT06611657
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials
- Conditions
- Cancer
- Interventions
- Drug: research drug in combination with Toripalimab
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2024-09-25
- Target Recruit Count
- 100
- Registration Number
- NCT06612632
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors
- Conditions
- Solid TumorMeningeal Metastasis
- Interventions
- Biological: QH104 Cell injection
- First Posted Date
- 2024-09-11
- Last Posted Date
- 2024-09-11
- Target Recruit Count
- 6
- Registration Number
- NCT06592092
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
- Conditions
- Renal Cell CarcinomaRCCKidney Cancer
- Interventions
- Radiation: Stereotactic Ablative Radiotherapy (SABR)
- First Posted Date
- 2024-09-06
- Last Posted Date
- 2024-09-06
- Target Recruit Count
- 60
- Registration Number
- NCT06585878
Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
- Conditions
- RCCKidney CancerRenal Cell Carcinoma
- Interventions
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2024-08-29
- Target Recruit Count
- 37
- Registration Number
- NCT06577961
Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Target Recruit Count
- 30
- Registration Number
- NCT06553365
ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Target Recruit Count
- 68
- Registration Number
- NCT06543836
- Locations
- 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
- Conditions
- Bone MetastasesBreast Cancer
- Interventions
- Other: Breast cancer patients with bone metastasisOther: Breast cancer patients without bone metastasis
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Target Recruit Count
- 3500
- Registration Number
- NCT06544668
- Locations
- 🇨🇳
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-07
- Target Recruit Count
- 47
- Registration Number
- NCT06540950
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China